Urinary monoamine metabolite excretion in disorders of movement
- 31 May 1977
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 32 (2), 219-225
- https://doi.org/10.1016/0022-510x(77)90237-4
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Interactions of L-dopa and amantadine in patients with ParkinsonismJournal of Neurology, Neurosurgery & Psychiatry, 1973
- Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and Parkinsonian subjectsJournal of the Neurological Sciences, 1972
- Observations on the use of methysergide in Huntington's choreaNeurology, 1972
- A new derivative for the gas-liquid chromatographic determination of homovanillic acidAnalytical Biochemistry, 1972
- 5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L-DOPAEuropean Journal of Clinical Pharmacology, 1971
- Effects ofl-DOPA treatment on indole metabolism in Parkinson's diseaseCellular and Molecular Life Sciences, 1971
- Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonismNeurology, 1970
- Urinary Excretion of Histamine, Methylhistamine and Methylimidazoleacetic Acids in Man under Standardized Dietary ConditionsScandinavian Journal of Clinical and Laboratory Investigation, 1968
- Dopamine metabolism in Parkinson's diseaseNeurology, 1963
- Drug-Induced Extrapyramidal ReactionsJAMA, 1961